FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1973302340> ?p ?o ?g. }

• W1973302340 endingPage "290" @default.
• W1973302340 startingPage "285" @default.
• W1973302340 abstract "Vox SanguinisVolume 74, Issue S2 p. 285-290 Evaluating the Clinical Significance of Blood Group Alloantibodies that are causing Problems in Pretransfusion Testing G. Garratty PhD, FRCPath, Corresponding Author G. Garratty PhD, FRCPath Scientific Director American Red Cross Blood Services Southern California Region Los Angeles, CA USAAmerican Red Cross Blood Services, Southern California Region 1130 South Vermont Avenue Los Angeles, CA 90006, USA Phone: +1 213 739 5580, Fax: +1 213 739 5455 [email protected]Search for more papers by this author G. Garratty PhD, FRCPath, Corresponding Author G. Garratty PhD, FRCPath Scientific Director American Red Cross Blood Services Southern California Region Los Angeles, CA USAAmerican Red Cross Blood Services, Southern California Region 1130 South Vermont Avenue Los Angeles, CA 90006, USA Phone: +1 213 739 5580, Fax: +1 213 739 5455 [email protected]Search for more papers by this author First published: 09 August 2011 https://doi.org/10.1111/j.1423-0410.1998.tb05433.xCitations: 16AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Mollison PL, Engelfriet CP, Contreras M: Blood transfusion in clinical medicine. 10th ed. Oxford: Blackwell Scientific, 1997. 2 Mollison PL: The clinical significance of red cell alloantibodies (and autoantibodies) in blood transfusion; in HF Polesky, RH Walker (eds): Safety in transfusion practices. Skokie, IL, College of American Pathologists, 1982, pp 131– 149. 3 Garratty G: Clinical significance and insignificance of antibodies reacting optimally at 37C; in S Butch (ed): Clinically significant and insignificant antibodies. Washington, DC, American Association of Blood Banks, 1979, pp 29– 49. 4 Issitt PD: Antibodies reactive at 30 centigrade, room temperature, and below; in S Butch (ed): Clinically significant and insignificant antibodies. Washington, DC, American Association of Blood Banks, 1979, pp 13– 28. 5 Garratty G: The significance of IgG on the red cell surface. Trans Med Rev 1987; 1: 47– 57. 6 Garratty G: The clinical significance (and insignificance) of red-cell-bound IgG and complement; in ME Wallace, JS Levitt (eds): Current applications and interpretation of the direct antiglobulin test. Arlington, VA, American Association of Blood Banks, 1988, pp 1– 24. 7 Garratty G: Factors affecting the pathogenicity of red cell auto- and alloantibodies; in SJ Nance (ed): Immune destruction of red blood cells. Arlington, VA, American Association of Blood Banks, 1989, pp 109– 169. 8 Mollison PL: Determination of red cell survival using 51Cr; in CA Bell (ed): A seminar on immune-mediated cell destruction. Washington, DC, American Association of Blood Banks, 1981, pp 45– 69. 9 Garratty G: Predicting the clinical significance of alloantibodies and determining the in vivo survival of transfused red cells; in: Clinical significance and serological aspects of transfusion reactions. Washington DC, American Association of Blood Banks, 1982, pp 91– 119. 10 Cutbush M, Mollison PL: Relation between characteristics of blood-group antibodies in vitro and associated patterns of red-cell destruction in vivo. Br J Haematol 1958; 2: 115– 137. 11 Mollison PL: Factors determining the relative clinical importance of different blood group antibodies. Br Med Bull 1959; 92– 98. 12 Giblett ER: Blood group alloantibodies: an assessment of some laboratory practices. Transfusion 1977; 17: 299– 307. 13 V Vengelen-Tyler, ed. Technical manual. 12th ed. Bethesda, Maryland, American Association of Blood Banks, 1996. 14 Judd WJ: Controversies in transfusion medicine. Prewarmed tests: Con. Transfusion 1995; 35: 271– 275. 15 Mallory D: Controversies in transfusion medicine. Prewarmed tests: Pro-why, when, and how - not if. Transfusion 1995; 35: 268– 270. 16 Garratty G: Attack on prewarmed tests - too much hot air? Transfusion 1996; 36: 192– 193. 17 International Committee for Standardization in Hematology: Recommended methods for radioisotope red cell survival studies. Blood 1971; 38: 378– 386. 18 International Committee for Standardization in Hematology: Recommended methods for radioisotope red cell survival studies. Br J Haematol 1980; 45: 659– 666. 19 Moore GL, Peck CC, Sohmer PR, Zuck TF: Some properties of blood stored in anticoagulant CPDA-1 solution. A brief summary. Transfusion 1981; 21: 135– 137. 20 Engelfriet CP, Ouwehand WH: ADCC and other cellular bioassays for predicting the clinical significance of red cell alloantibodies; in M Contreras (ed): Baillière's clinical haematology. London, Baillière Tindall, 1990, pp 321– 327. 21 Garratty G: Predicting the clinical significance of red cell antibodies with in vitro cellular assays. Trans Med Rev 1990; IV: 297– 312. 22 Zupanska B: Cellular immunoassays and their use for predicting the clinical significance of antibodies; in G Garratty (ed): Immunobiology of transfusion medicine. New York, Dekker, 1994, pp 465– 491. 23 Hadley AG, Poole J, Arndt P, Garratty G: A chemiluminescence test for predicting the outcome of transfusing incompatible blood. Transfusion 1995; 35: 20S (abstract). 24 Arndt P, Garratty G: Measuring interactions of monocytes with IgG sensitized RBCs using flow cytometry. Transfusion 1992; 22: 21S (abstract). 25 Bratosin D, Mazurier J, Slomianny C, Aminoff D, Montreuil J: Molecular mechanisms of erythrophagocytosis: flow cytometric quantitation of in vitro erythrocyte phagocytosis by macrophages. Cytometry 1997; 30: 269– 274. 26 Hoffman JJML, Overbeeke MAM: Characteristics of anti-Cob in vitro and in vivo: a case study. Immunohematology 1996; 12: 11– 13. 27 Nance S, Garratty G: Correlations between an in vitro monocyte monolayer assay and autoimmune hemolytic anemia (AIHA). Transfusion 1982; 22: 410 (abstract). 28 Nance S, Nelson J, O'Neill P, Garratty G: Correlation of monocyte monolayer assays, maternal antibody titers, and clinical course in hemolytic disease of the newborn (HDN). Transfusion 1984; 24: 415 (abstract). 29 Nance S, Nelson JM, Horenstein J, Arndt PA, Platt LD, Garratty G: Monocyte monolayer assay - an efficient non-invasive technique for predicting the severity of hemolytic disease of the newborn. Am J Clin Pathol 1989; 92; 89– 92. 30 Garratty G, Nance S, O'Neill P. Correlation of monocyte monolayer assays and RBC survival in patients with alloantibodies of questionable clinical significance. Transfusion 1985; 25: 474 (abstract). 31 Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987; 27: 449– 452. 32 Levy GJ, Selset G, McQuiston D, Nance SJ, Garratty G, Smith LE, Goldfinger D: Clinical significance of anti-Ytb; Report of a case using 51Chromium red cell survival study. Transfusion 1988; 28: 265– 267. 33 Garratty G, Arndt P, Nance S: The potential clinical significance of blood group alloantibodies to high frequency antigens. Blood 1997; 90: 473a (abstract). 34 Leger R, Amdt P, Co A, O'Brien L, Garratty G: Clinical significance of an anti-Dib assessed by flow cytometry. Immunohematology 1997; 13: 93– 96. 35 AuBuchon JP, Brightman A, Anderson HJ, Kim B: An example of anti-Yta demonstrating a change in its clinical significance. Vox Sang 1988; 55: 171– 175. 36 Baldwin ML, Ness PM, Barrasso C, Kickler TS, Drew H, Tsan M-F, Shirey RS: In vivo studies of the long-term 5lCr red cell survival of serologically incompatible red cell units. Transfusion 1985; 25: 34– 38. 37 Garratty G, Arndt P, Nance S: IgG subclass of blood group alloantibodies to high frequency antigens. Transfusion 1996; 36: 50S (abstract). 38 Tyler VV, Morel PA: Serological and IgG subclass characterization of multiple examples of Cartwrighta (Yta) and Gerbich antibodies. Transfusion 1979; 19: 650 (abstract). 39 Molthan L: Transfusion reaction presumably due to anti-Bga. Transfusion 1979; 19: 609– 610. 40 Panzer S, Mueller-Eckhardt G, Salama A, Strauss BE, Kiefel V, Mueller-Eckhardt C: The clinical significance of HLA antigens on red cells. Transfusion 1984; 24: 486– 489. 41 Panzer S, Mayr WR, Graninger W, Püchler K, Höcker, Lechner K: Haemolytic transfusion reactions due to HLA antibodies. The Lancet 1987; 1: 474– 477. 42 Molthan L: Biological significance of the York, Cost, McCoy and Knops alloantibodies. Blood Transfusion and Immunohaematology 1982; XXV: 127– 147. 43 Mudad R, Rao N, Issitt PD, Roy RB, Combs MR, Telen MJ: JMH variants: serologic, clinical, and biochemical analyses in two cases. Transfusion 1995; 35: 925– 930. Citing Literature Volume74, IssueS2June 1998Pages 285-290 ReferencesRelatedInformation" @default.
• W1973302340 created "2016-06-24" @default.
• W1973302340 creator A5086688222 @default.
• W1973302340 date "1998-06-01" @default.
• W1973302340 modified "2023-09-26" @default.
• W1973302340 title "Evaluating the Clinical Significance of Blood Group Alloantibodies that are causing Problems in Pretransfusion Testing" @default.
• W1973302340 cites W144605883 @default.
• W1973302340 cites W1577609372 @default.
• W1973302340 cites W1973370122 @default.
• W1973302340 cites W1973663367 @default.
• W1973302340 cites W1978683075 @default.
• W1973302340 cites W1983685987 @default.
• W1973302340 cites W1996912484 @default.
• W1973302340 cites W2009284161 @default.
• W1973302340 cites W2009884511 @default.
• W1973302340 cites W2017301648 @default.
• W1973302340 cites W2035895946 @default.
• W1973302340 cites W2054022437 @default.
• W1973302340 cites W2070114270 @default.
• W1973302340 cites W2095114611 @default.
• W1973302340 cites W2100840148 @default.
• W1973302340 cites W2119065140 @default.
• W1973302340 cites W2319963722 @default.
• W1973302340 cites W2340339809 @default.
• W1973302340 cites W2412054986 @default.
• W1973302340 cites W2739917692 @default.
• W1973302340 cites W4214893205 @default.
• W1973302340 cites W4251951610 @default.
• W1973302340 doi "https://doi.org/10.1111/j.1423-0410.1998.tb05433.x" @default.
• W1973302340 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9704458" @default.
• W1973302340 hasPublicationYear "1998" @default.
• W1973302340 type Work @default.
• W1973302340 sameAs 1973302340 @default.
• W1973302340 citedByCount "17" @default.
• W1973302340 countsByYear W19733023402014 @default.
• W1973302340 countsByYear W19733023402015 @default.
• W1973302340 countsByYear W19733023402016 @default.
• W1973302340 countsByYear W19733023402017 @default.
• W1973302340 countsByYear W19733023402018 @default.
• W1973302340 countsByYear W19733023402019 @default.
• W1973302340 countsByYear W19733023402021 @default.
• W1973302340 crossrefType "journal-article" @default.
• W1973302340 hasAuthorship W1973302340A5086688222 @default.
• W1973302340 hasConcept C159654299 @default.
• W1973302340 hasConcept C177713679 @default.
• W1973302340 hasConcept C203014093 @default.
• W1973302340 hasConcept C2778430493 @default.
• W1973302340 hasConcept C3019670348 @default.
• W1973302340 hasConcept C71924100 @default.
• W1973302340 hasConceptScore W1973302340C159654299 @default.
• W1973302340 hasConceptScore W1973302340C177713679 @default.
• W1973302340 hasConceptScore W1973302340C203014093 @default.
• W1973302340 hasConceptScore W1973302340C2778430493 @default.
• W1973302340 hasConceptScore W1973302340C3019670348 @default.
• W1973302340 hasConceptScore W1973302340C71924100 @default.
• W1973302340 hasIssue "S2" @default.
• W1973302340 hasLocation W19733023401 @default.
• W1973302340 hasLocation W19733023402 @default.
• W1973302340 hasOpenAccess W1973302340 @default.
• W1973302340 hasPrimaryLocation W19733023401 @default.
• W1973302340 hasRelatedWork W2023463494 @default.
• W1973302340 hasRelatedWork W2031133170 @default.
• W1973302340 hasRelatedWork W2040191638 @default.
• W1973302340 hasRelatedWork W2093828525 @default.
• W1973302340 hasRelatedWork W2103974498 @default.
• W1973302340 hasRelatedWork W2140167340 @default.
• W1973302340 hasRelatedWork W2557579740 @default.
• W1973302340 hasRelatedWork W2893313524 @default.
• W1973302340 hasRelatedWork W3043655495 @default.
• W1973302340 hasRelatedWork W4234015570 @default.
• W1973302340 hasVolume "74" @default.
• W1973302340 isParatext "false" @default.
• W1973302340 isRetracted "false" @default.
• W1973302340 magId "1973302340" @default.
• W1973302340 workType "article" @default.